Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients

Onur Hurşıtoğlu, Ergül Belge Kurutaş, Rebecca Strawbridge, Erkan Öner, Meltem Güngör, Taha Can Tuman, Ömer Faruk Uygur

2022Progress in Neuro-Psychopharmacology and Biological Psychiatry17 citationsDOI

Topics & Concepts

NOX1Major depressive disorderOxidative stressHamdDepression (economics)BiomarkerInternal medicineMedicineBody mass indexPathogenesisPsychologyOncologyNADPH oxidaseBiologyAmygdalaBiochemistrySignificant differenceMacroeconomicsEconomicsTryptophan and brain disordersStress Responses and CortisolTreatment of Major Depression